Sumitomo Mitsui Ds Asset Management Company, LTD Amgen Inc Transaction History

Sumitomo Mitsui Ds Asset Management Company, LTD

$9.15 Billion
Q3 2024

A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Amgen Inc stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 282,927 shares of AMGN stock, worth $77 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

282,927

Previous 271,347 4.27%

Holding current value

$77 Million

Previous $84.8 Million 7.52%

% of portfolio

1.0%

Previous 1.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$309.38 - $337.38 $3.58 Million - $3.91 Million	11,580 Added 4.27%	282,927 $91.2 Million
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $2.25 Million - $2.74 Million	8,570 Added 3.26%	271,347 $84.8 Million
Q1 2024 May 02, 2024	BUY	$268.87 - $324.56 $4.47 Million - $5.39 Million	16,619 Added 6.75%	262,777 $74.7 Million
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $625,697 - $705,861	-2,447 Reduced 0.98%	246,158 $70.9 Million
Q3 2023 Oct 30, 2023	BUY	$218.65 - $271.46 $1.94 Million - $2.41 Million	8,887 Added 3.71%	248,605 $66.8 Million
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $1.88 Million - $2.22 Million	8,763 Added 3.79%	239,718 $53.2 Million
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $6.31 Million - $7.69 Million	27,936 Added 13.76%	230,955 $55.8 Million
Q4 2022 Jan 26, 2023	BUY	$229.03 - $291.01 $4.77 Million - $6.06 Million	20,810 Added 11.42%	203,019 $0
Q3 2022 Oct 19, 2022	BUY	$224.46 - $253.15 $4.82 Million - $5.44 Million	21,488 Added 13.37%	182,209 $41.1 Million
Q2 2022 Jul 13, 2022	BUY	$230.71 - $256.74 $3.84 Million - $4.27 Million	16,630 Added 11.54%	160,721 $39.1 Million
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $3.78 Million - $4.18 Million	17,226 Added 13.58%	144,091 $34.8 Million
Q4 2021 Jan 20, 2022	BUY	$198.88 - $227.6 $937,520 - $1.07 Million	4,714 Added 3.86%	126,865 $28.5 Million
Q3 2021 Oct 15, 2021	BUY	$212.27 - $248.7 $1.54 Million - $1.8 Million	7,233 Added 6.29%	122,151 $26 Million
Q2 2021 Jul 19, 2021	BUY	$233.58 - $259.14 $1.48 Million - $1.64 Million	6,335 Added 5.83%	114,918 $28 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $431,614 - $502,977	-1,945 Reduced 1.76%	108,583 $27 Million
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $2.38 Million - $2.84 Million	-11,003 Reduced 9.05%	110,528 $25.4 Million
Q3 2020 Oct 29, 2020	BUY	$234.65 - $260.95 $19.7 Million - $22 Million	84,134 Added 224.98%	121,531 $30.9 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $59,540 - $73,064	-301 Reduced 0.8%	37,397 $8.82 Million
Q1 2020 Apr 21, 2020	BUY	$182.24 - $241.7 $1,640 - $2,175	9 Added 0.02%	37,698 $7.64 Million
Q4 2019 Jan 24, 2020	SELL	$189.21 - $243.2 $2,838 - $3,648	-15 Reduced 0.04%	37,689 $9.09 Million
Q3 2019 Oct 16, 2019	BUY	$174.11 - $208.62 $472,186 - $565,777	2,712 Added 7.75%	37,704 $7.3 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $1.55 Million - $1.82 Million	-9,326 Reduced 21.04%	34,992 $6.45 Million
Q1 2019 May 07, 2019	BUY	$180.87 - $203.88 $192,264 - $216,724	1,063 Added 2.46%	44,318 $8.42 Million
Q4 2018 Jan 25, 2019	SELL	$178.4 - $208.25 $591,752 - $690,765	-3,317 Reduced 7.12%	43,255 $8.42 Million
Q3 2018 Oct 15, 2018	SELL	$185.29 - $208.89 $116,732 - $131,600	-630 Reduced 1.33%	46,572 $9.65 Million
Q2 2018 Jul 31, 2018	BUY	$166.05 - $186.51 $68,412 - $76,842	412 Added 0.88%	47,202 $8.71 Million
Q1 2018 Apr 25, 2018	SELL	$169.43 - $198.0 $998,112 - $1.17 Million	-5,891 Reduced 11.18%	46,790 $7.98 Million
Q4 2017 Jan 25, 2018	SELL	$168.79 - $188.59 $628,573 - $702,309	-3,724 Reduced 6.6%	52,681 $9.16 Million
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $9.44 Million - $10.8 Million	56,405	56,405 $10.5 Million

Others Institutions Holding AMGN

# of Institutions

3,097

Shares Held

406M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.

Account

Sumitomo Mitsui Ds Asset Management Company, LTD Amgen Inc Transaction History